Navigation Links
Eight in Biological Technology

Xceed Meets HTX/CIHR Grant Milestone: Decreasing Sample-Prep Time From Days to Less Than Eight Hours

Ziplex automated gene-expression system featured as platform of choice on Health Technology Exchange Web site - www.htx.ca WELLESLEY, Mass., June 4 /PRNewswire/ -- Xceed Molecular, a pioneer in the development of cost-effective, easy-to-use gene-expression analysis systems, announced that ...

Regal Introduces Four, Six and Eight Port Filtered and Un-Filtered Right Angle BNC Connectors

Regal Electronics has added four, six and eight port right-angle BNC connectors to its product line. The multi-port BNC connectors represent potential manufacturing cost savings as a replacement for applications where a number of single or dual port BNC connectors are currently being used. ...

P2R Associates Presented with Eight MarCom Awards for Client Strategic Communication Programs

LIVONIA, Mich., Jan. 22 /PRNewswire/ -- P2R Associates today announced it received eight prestigious MarCom Awards sponsored by the Association of Marketing and Communication Professionals. The awards were presented recognizing outstanding creative achievement by marketing and communication p...

You Want To Have a Baby...But Not Eight

Multiple births can be avoided ATLANTA, Jan. 30 /PRNewswire/ --For the many women experiencing infertility issues but now are hesitant to seek help after this week's birth of octuplets in California, the message to them is that multiple births can be prevented with today's advanced technologi...

Tech council adds eight to board of directors

Madison, Wis. The Wisconsin Technology Council , a policy advisor to the governor and the legislature with statewide membership arms, has announced eight additions to its board of directors. The new members have three-year terms and will join a board that includes more than three dozen membe...

PharmatrophiX, Initially Funded by the Alzheimer's Drug Discovery Foundation, Announces Exclusive Global Collaboration with Elan

...t, treat, and cure Alzheimer's disease and cognitive aging. The journey began when Frank Longo, M.D., Ph.D., began receiving funding from ADDF eight years ago while at UCSF (and then later at University of North Carolina) to find small molecules with the features of large biological agents that cou...

Repligen Reports First Quarter Fiscal Year 2010 Financial Results

... placebo-controlled clinical trial in which approximately 150 patients with bipolar depression will receive either RG2417 or a placebo twice a day for eight weeks. The study is designed to assess the safety and efficacy of RG2417 on the symptoms of depression as measured by the Montgomery-Asberg Depressio...

UCLA welcomes startup to new incubator space at California NanoSystems Institute

...p companies and early-stage technology research projects that originate at UCLA. The incubator offers shared, flexible lab space dedicated to housing eight to 10 early-stage incubation projects for short periods of time. "The incubator program is an important way for UCLA to make the fruits of our worl...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results

...ed methodology demonstrated that all of the evaluable baseline samples had detectable interstitial capillary GL-3 and that reductions were observed in eight of the nine responders. It is expected that approximately 30 clinical sites worldwide will participate in this trial. Plicera (TM...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

...salamine market to 15.9% (2008: 10.8%) and underlying growth in the US oral mesalamine market of 4%. By June 30, 2009 MEZAVANT was available in eight countries outside the US, and further launches are planned in other countries throughout 2009 and 2010, subject to the successful conclusion of pricin...

Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer

...er (NSCLC). As of the time of data analysis in April 2009, 10 of the 16 studied patients were alive without evidence of disease progression, of whom eight continued to receive therapy with Stimuvax after 6.3 to 8.2 years. The remaining two living patients discontinued Stimuvax therapy after 2.4 and 5.8 y...

Oncolytics Biotech(R) Inc. Announces 2009 Second Quarter Results

...nd demonstrated anti-tumour activity in a U.S. Phase I systemic administration monotherapy trial. Of 18 patients treated in the trial, eight demonstrated SD or better as measured by Response Evaluation Criteria in Solid Tumors (RECIST) including a patient with progressive br...

Kendle Appoints Stephen Cutler, PhD Senior Vice President and Chief Operating Officer

...and served in executive sponsor roles for key customer relationships. Prior to joining Quintiles Dr. Cutler was with Sandoz (now Novartis) for eight years in Australia and Europe where he served as a Group Head providing leadership for Phase I-III trials in a broad spectrum of therapeutic areas. He...

The MedZilla Report: June 2009 Employment Outlook for Biotech/Pharma/Health

... was also home to the biggest month-to-month jump in candidate search activities -- that is, companies actively seeking out new employees. They topped eight percent. Three states increased by more than three percent, and three more by more than two. Illinois-based companies slowed their search efforts by m...

Schering-Plough Reports Financial Results for 2009 Second Quarter

...SMANEX (mometasone furoate) for asthma and REMERON (mirtazapine) for depression; these approvals bring the number of new products approved in Japan to eight since the beginning of 2007; Positive opinion from the EU's regulatory authority in June recommending approval of SIMPONI as a once-monthly, sub...

Wyeth Announces Stockholder Approval of Pfizer Merger at 2009 Annual Meeting

...als. Wyeth's patient-focused business units in these areas will be backed by the scale and resources of a global enterprise. We're very pleased that eight members of Wyeth's senior management team will assume significant leadership roles in R&D and commercial operations in the combined organization p...

Health Robotics to Launch Germany's Installations of i.v.STATION(TM) at Charite-Universitatsmedizin Berlin

...itals in Germany and among the largest of university clinics in Europe today. With a history spanning almost three centuries, the Charite has produced eight Nobel prize winners and has a worldwide reputation for excellence in medicine and research. Currently, with a staff of 10,400 employees, the hospital ...

NeoStem, Inc. Appoints Leading Chinese Medical Official to Its Advisory Board

... head Chinese Medical Affairs of Shandong province, and during her tenure the number of Chinese medicine hospitals in Shandong province increased from eight to 150. In addition to being responsible for having established the Shandong Academy of Chinese Medicine and the Shandong Academy of Acupuncture and ...

EnVivo Pharmaceuticals Announces Results and Successful Completion of EVP-6124 Phase Ib/IIa Trial at the International Conference on Alzheimer's Disease

...bserved compared to placebo treated patients. These included measures of attention, verbal and language fluency, and executive function. Four of the eight cognition measures showed statistically significant dose-dependent effects and two others showed a trend towards improvement. Based on the su...

New Scientific Worldview 'Biocentrism' Featured in The Huffington Post - #1 Weblog in the World

...ffers a more promising way to bring together all of science as scientists have been attempting to do ever since Einstein's 'unified field' theories of eight decades ago. Until we recognize the universe in our heads, attempts to truly understand the world will remain a road to nowhere." Click this ...

Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009

... Enzon Pharmaceuticals, Santaris Pharma will design and generate a total of eight drug candidates and Enzon will fund and manage the preclinical- and clinica...utside Europe. Santaris Pharma has maintained all commercial rights for the eight drug candidates in Europe. Enzon is expected to disclose final resul...

Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease

...than 33 million Americans from a managed care population over the course of eight years. The study authors concluded that the most notable serious condition... About Alzheimer's Disease It is estimated that one in eight baby boomers will develop AD, resulting in significant costs to society and...

Sparta Systems' TrackWise(R) Solution Delivers Workforce Training and Learning Initiatives for Cangene Corporation

...d earliest biopharmaceutical companies. It was founded in 1984 and is headquartered in Winnipeg, Manitoba. Cangene has approximately 700 employees in eight locations across North America and its products are sold worldwide. It operates three large manufacturing facilities where it produces its own produc...

Dr. Daniel Ronel Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler

...r the correction of nasolabial folds, better known as smile lines. The safety and effectiveness of Artefill has been extensively studied over the past eight years. Since Artefill was approved in 2006, over 10 thousand patients have been treated successfully with very high satisfaction rates. Suneva ...

OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $15 Million Milestone in Patient Financial Assistance

... go without treatment due to the high cost. Our service helps those patients stay on therapy by seeking funds to offset their cost." In the last eight months, OncologyRx Care Advantage has helped more than 1,300 patients receive more than $5 million in financial assistance from charitable foundations...

Amylin Pharmaceuticals Announces Positive Results from Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment for Obesity

...owing a one-week placebo lead-in period, study subjects were randomized in a balanced fashion to receive twice-daily therapy with one of the following eight treatment regimens: 1) placebo/placebo; 2) pramlintide 360 mcg/placebo; 3) metreleptin 5 mg/placebo; 4) pramlintide 180 mcg/metreleptin 2.5 mg; 5) pra...

Researchers unite to distribute quantum keys

...n network ever built. The efforts of 41 research and industrial organisations were realised as secure, quantum encrypted information was sent over an eight node, mesh network. With an average link length of 20 to 30 kilometres, and the longest link being 83 kilometres, the researchers from organisation...

Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa

... by rFSH (maximum 200 IU/day) from stimulation day eight onward, when required. Starting on stimulation da...pin beta (maximum 200 IU/day) from stimulation day eight onwards when required, to reach the criterion for ...daily rFSH (follitropin beta) from stimulation day eight until the day of triggering oocyte maturation. Fi...

Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August

... osteoporosis is a global problem that is increasing in significance as the population of the world both increases and ages. In the U.S. today, nearly eight million women suffer from osteoporosis.(i) The World Health Organization (WHO) has recently identified osteoporosis as a priority health issue along w...

Dragon Pharma Announces Results of 2009 Annual General Meeting

...China. There were 50,209,377 shares equaling 74.87% of the outstanding shares represented at this meeting. The shareholders re-elected the following eight persons to serve as members of the Board of Directors for the Company: Mr. Yanlin Han, Mr. Zhanguo Weng, Ms. Xuemei Liu, Dr. Alexander Wick, Ph.D., Dr...

BD and FIND Achieve Milestone in Global Battle Against MDR-TB

...fter the WHO's Strategic and Technical Advisory Group for TB recommended liquid culture technology based on demonstration studies conducted by FIND in eight countries. BD and FIND announced the price reduction today at the Pacific Health Summit, which is held annually in Seattle, WA. The Summit's 20...

Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results

... placebo-controlled clinical trial in which approximately 150 patients with bipolar depression will receive either RG2417 or a placebo twice a day for eight weeks. The study is designed to assess the safety and efficacy of RG2417 on the symptoms of depression as measured by the Montgomery-Asberg Depressio...

University of Texas 'Picosatellite' to be launched from space shuttle to begin milestone mission

...partment of Aerospace Engineering and Engineering Mechanics and principal investigator of the project. It's the first of four missions planned over eight years that include a gradual build-up to the goal of rendezvous and docking: having the two satellites, or spacecraft, meeting at a desired point in s...

LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit

...taris Pharma A/S. The collaboration between Santaris Pharma and Enzon Pharmaceuticals started in 2006 and by 2008 Santaris Pharma had delivered eight LNA based cancer drugs to Enzon Pharmaceuticals of which EZN-2968 was the first. The development of the remaining seven compounds is in progress. Movi...

Visage Imaging to Provide Visage(R) CS Enterprise Wide Advanced Visualization Solutions to Advanced Radiology Consultants

...(R) CS. Based in southern Fairfield County, Connecticut, Advanced Radiology Consultants is a multi-modality, multi-site imaging organization with eight imaging centers performing over 150,000 procedures per year. Dr. Gerard Muro, Chief of neuroradiology of Advanced Radiology noted, "The enterpris...

Amylin Announces Preliminary Tabulation of Annual Meeting Results

...May 27, 2009, has completed its preliminary tabulation of shareholder votes. The preliminary tabulation indicates that shareholders voted to re-elect eight of the Company's current Directors to Amylin's Board of Directors - Adrian Adams, Steven R. Altman, Teresa Beck, Daniel M. Bradbury, Karin Eastham, Dr...

Laboratory Test May Predict Effectiveness of ERBITUX(R) for Individual Colorectal Cancer Patients

...ults from the study show that of the 54 primary colorectal cultures tested, eight percent were responsive to cetuximab, a result that is consistent with the .... Dose-response curves of the 54 primary colorectal cultures revealed that eight (8) percent of the cultures tested were responsive to cetuximab, 22 percent...

Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meeting

...umors." The results, which were previously announced in June 2007, demonstrated that REOLYSIN was well tolerated. Of 18 patients treated in the trial, eight demonstrated SD or better as measured by Response Evaluation Criteria in Solid Tumors (RECIST) including a patient with progressive breast cancer who ...

Oncothyreon announces clinical data from three product candidates presented at American Society of Clinical Oncology (ASCO) Annual Meeting

...died. Ten of these patients have been treated for more than five years, and eight continue to receive therapy with Stimuvax. Prolonged treatment with Stimuva...as been able to continue to receive Stimuvax with apparent safety for up to eight years," said Robert L. Kirkman, M.D., President and Chief Executive Officer...

DuPont Named Among Best Places to Work by The Scientist Magazine

...t magazine representing 238 biotechnology businesses worldwide. Respondents were asked to assess their working environment according to 45 criteria in eight different categories, including job satisfaction, benefits, training and integrity. The Best Places to Work in Industry survey rankings and detai...
Other Tags
(Date:9/2/2014)... to prevent Type 2 diabetes, don,t get your hopes up. ... The FASEB Journal , suggests that you don,t ... study compared genetically identical twins-one heavier and one leaner-and found ... those related to Type 2 diabetes, were found in both ... the onset of this type of diabetes is largely influenced ...
(Date:9/2/2014)... your integrity? Tell the truth; everyone has a tipping point. ... we,ll lie if the benefit is great enough. Now, scientists ... make that decision. , The result was published online ... "We prefer to be honest, even if lying is beneficial," ... associate at the Virginia Tech Carilion Research Institute , ...
(Date:9/2/2014)... limestone is well known as a result of ... (for example, Archaeopteryx). Now, for the first time, ... equivalent of these outcrops - discoveries which include ... treader. , Despite the abundance of fossils in ... obtained from the Late Kimmeridgian equivalents of these ...
Breaking Biology News(10 mins):What you eat and not just the number of calories, is a significant factor in diabetes risk 2Scientists find possible neurobiological basis for tradeoff between honesty, self-interest 2Scientists find possible neurobiological basis for tradeoff between honesty, self-interest 3Scientists find possible neurobiological basis for tradeoff between honesty, self-interest 4Exceptionally well preserved insect fossils from the Rhône Valley 2
(Date:9/2/2014)... TUESDAY, Sept. 2, 2014 (HealthDay News) -- Complications ... mastectomy and reconstruction, a new study indicates. ... mastectomy was associated with a slightly higher risk ... The study included more than 18,000 breast cancer ... a double mastectomy with breast reconstruction and were ...
(Date:9/2/2014)... women diagnosed with early-stage breast cancer in California, the ... and 2011, although this procedure was not associated with ... radiation, according to a study in the September 3 ... that surgery for the removal of one breast was ... other options examined in the study. , Randomized trials ...
(Date:9/2/2014)... for their own spread throughout the body by coaxing ... according to a new report by Johns Hopkins scientists. ... Nature Communications , the researchers describe animal and cell-culture ... released by breast cancer cells. These molecules cause lymphatic ... to produce proteins called CCL5 and VEGF. CCL5 attracts ...
(Date:9/2/2014)... Medex Analytic Services is delighted to ... Coral Springs, Fla. due to their greater than forecasted ... for the 2014 year by distinguishing Medex in the ... a higher level of service and professionalism in the ... the industry has responded.” , The location of the ...
(Date:9/2/2014)... Operators in the Community Services industry ... care and counsel for those in need. In 2014-15, ... derive $39.4 billion in revenue, which includes a combination ... five years through 2014-15, the subdivision is forecast to ... of 4.1% in 2014-15. , As the population ages ...
Breaking Medicine News(10 mins):Health News:Complication Rates Low With Mastectomy, Breast Reconstruction: Study 2Health News:Increase seen in use of double mastectomy 2Health News:Increase seen in use of double mastectomy 3Health News:‘Prepped’ by tumor cells, lymphatic cells encourage breast cancer cells to spread 2Health News:Medex Analytic Services Announces New Location for Corporate Headquarters 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 3
Other Contents